Ricardo Becerro de Bengoa Vallejo
Madrid, 28040, Spain
NCT Number: NCT04446923
The present study evaluates the effects of to compare bactericidal efficacy using the reference antiseptic product propan-ol-1 60% using the hand rub method versus hand scrub method in order to test if pass the standard european norm 12791.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Phase 4
Madrid, 28040, Spain
The investigators conducted a crossover clinical trial to evaluate the antiseptic effectiveness of preoperative surgical scrubbing using propan-ol-1 60% by rub and scrub. Samples will be taken from the hands of each volunteer after a surgical hands antiseptic.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Surgical Hand scrubbing using P-1 of both hands using a sterile disposable surgical scrub brush with plastic bristles on one side and a foam sponge on the other side.
Other names: Propanolol
Time frame: Change from bacterial load at 5 minutes.
Participants will scrub the liquid vigorously from hand to the wrists according with the standard handrub procedure.
Time frame: Change from bacterial load at 3 hours.
Participants will scrub the liquid vigorously from hand to the wrists according with the standard handrub procedure after 3 hours
Universidad Complutense de Madrid
Other
Surgical Hand Antisepsis With Propan-ol-1 60% Per Rubbing and Scrubbing in Accordance With European Norm Regulation 12791
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02500758
Infections, Pathologic Processes
View Trial DetailsNCT06279143
BCC, BCC - Basal Cell Carcinoma
Vejle, Region of Southern Danmark, Denmark
View Trial DetailsNCT06092866
Digestive System Diseases, Gastro-Intestinal Disorder
Malmö, Region Skane, Sweden
View Trial DetailsNCT06237036
Chronic Disease, Disease Attributes
Torrejón de Ardoz, Madrid, Spain
View Trial Details